Experts discuss best practices for educating patients with multiple myeloma on the adverse effects associated with talquetamab treatment.
Stay up to date on recent advances in oncology nursing and patient care.
Subcutaneous Daratumumab Reduces Smoldering Myeloma Progression
Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies
Managing CRS in Hematologic Cancers: A Nursing Perspective
Beth Faiman Discusses Recent Changes in Multiple Myeloma Treatment Landscape
Personalizing Neurotoxicity Monitoring After CAR T-Cell Therapy
What Are the Barriers to CAR T-Cell Therapy Access in Multiple Myeloma?
Nurses Lead Toxicity Monitoring in Indolent Lymphoma Care
Osimertinib/Chemo Boosts Survival in Frontline EGFR+ NSCLC
Lutetium Lu 177 Dotatate Brings Partial Response in Metastatic BP-NETs
Safety Management With Amivantamab Plus Lazertinib in NSCLC